Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Nabiallah Mohammadi"'
Publikováno v:
Journal of Mazandaran University of Medical Sciences, Vol 30, Iss 190, Pp 1-10 (2020)
Background and purpose: Dendritic cells are professional antigen presenting cells that initiate and modulate immune responses. Epigallocatechin gallate (EGCG) is identified as a prophylactic agent that can suppress tumor formation. This research aime
Externí odkaz:
https://doaj.org/article/bd89302783b74c18a07ea97de6de677f
Publikováno v:
Iranian Journal of Allergy, Asthma and Immunology, Vol 18, Iss 5 (2019)
Stromal cell-derived factor-1 alpha (SDF-1α) has been shown to be up-regulated in a variety of malignancies. So that, its expression is associated with poor prognosis and invasiveness. Natural killer (NK) cells are important effector cells against v
Externí odkaz:
https://doaj.org/article/eadfcb34cb4148719b93da9bd06ed623
Publikováno v:
Naunyn-Schmiedeberg's Archives of Pharmacology.
Autor:
Reza Rahbarghazi, Alireza Mardomi, Nabiallah Mohammadi, Saeid Abediankenari, Bahareh Hasani, Shabanali K. Limoni, Hossein Ranjbaran, Narjes Jafari, Hadi Hossein Nataj, Mohsen Khorashadizadeh
Publikováno v:
Journal of cellular physiologyREFERENCES. 236(9)
Although the autologously transplanted cells are immunologically durable, allogeneic cell transplantation is inevitable in a series of cases. Mesenchymal stem cells (MSCs) are one of the suitable candidates for cardiac tissue regeneration that have b
Autor:
Alireza Rafiei, Seyed Ehsan Enderami, Alireza Mardomi, Hadi Hassannia, Hossein Ranjbaran, Nabiallah Mohammadi, Saeid Abediankenari
Publikováno v:
Immunobiology. 225(5)
Background Although mesenchymal stem cells (MSCs) are regarded as immune-elusive and even immunosuppressive, recent evidence suggests that allogeneic immune response might is inevitable in the case of some lineages differentiated from MSCs. Regarding
Publikováno v:
Journal of cellular physiologyREFERENCES. 235(5)
The promising outcomes of immune-checkpoint based immunotherapies in cancer have provided a proportional perspective ahead of exploiting similar approaches in allotransplantation. Belatacept (CTLA-4-Ig) is an example of costimulation blockers success
Publikováno v:
Journal of Neuroimmunology. :164